NEW EVENT! Cutting-edge Trends for Life Sciences at PACK EXPO Southeast
Discover all the latest packaging solutions for life sciences products at the all-new PACK EXPO Southeast in Atlanta, GA, March 10-12, 2025

FDA Greenlights Generic Vyvanse

The approval offers a more accessible alternative for managing ADHD and binge eating disorder.

Screen Shot 2022 04 18 At 2 47 13 Pm
Getty Images

According to a recent Forbes article, the FDA has taken a major step toward addressing the shortage of ADHD medications by granting approval for generic versions of Vyvanse, an increasingly sought-after alternative to Adderall. Vyvanse, commonly prescribed for ADHD and binge eating disorder, is used by over one million Americans. Previously manufactured exclusively by Takeda Pharmaceuticals, Vyvanse has generated substantial revenue, becoming Takeda's third-largest drug, with annual sales exceeding $2.5 billion.

INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
Read More
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast